Search

Search Constraints

You searched for: Author/Creator Westers, Theresia M.

Search Results

1. A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes. Issue 1 (18th February 2022)

2. A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin1. Issue 2 (16th January 2013)

3. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes. Issue 3 (28th January 2014)

5. Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow Cytometry Working Group. Issue 1 (13th December 2021)

8. Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype. (25th March 2021)

9. Dysplasia and PNH‐type cells in bone marrow aspirates of myelodysplastic syndromes. Issue 2 (22nd November 2021)

10. ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry. Issue 1 (30th December 2021)